France Tumor Ablation Market Size & Outlook, 2023-2030
France tumor ablation market, 2018-2030 (US$M)
Related Markets
France tumor ablation market highlights
- The France tumor ablation market generated a revenue of USD 80.9 million in 2023 and is expected to reach USD 191.8 million by 2030.
- The France market is expected to grow at a CAGR of 13.1% from 2024 to 2030.
- In terms of segment, radiofrequency ablation was the largest revenue generating technology in 2023.
- Other Ablation Technologies is the most lucrative technology segment registering the fastest growth during the forecast period.
Tumor ablation market data book summary
| Market revenue in 2023 | USD 80.9 million |
| Market revenue in 2030 | USD 191.8 million |
| Growth rate | 13.1% (CAGR from 2023 to 2030) |
| Largest segment | Radiofrequency ablation |
| Fastest growing segment | Other Ablation Technologies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
Other key industry trends
- In terms of revenue, France accounted for 4.8% of the global tumor ablation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany tumor ablation market is projected to lead the regional market in terms of revenue in 2030.
- Russia is the fastest growing regional market in Europe and is projected to reach USD 65.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tumor Ablation Market Scope
Tumor Ablation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France tumor ablation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.49% in 2023. Horizon Databook has segmented the France tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
The government of France is undertaking initiatives to improve the healthcare structure in France. The French Commonwealth Fund aids hospitals in France in staffing & improving their services. This is expected to create demand for tumor ablation devices in France.
Moreover, supportive government initiatives and improved lifestyle preferences of individuals are likely to help decrease mortality rates. Technological advancements are anticipated to fuel the market in this country.
France has a strong healthcare infrastructure, which meets the healthcare needs of its citizens. This favors the use of advanced ultrasound devices. With the increasing geriatric population, investments in tumor ablation devices are also rising in the country.
Reasons to subscribe to France tumor ablation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France tumor ablation market databook
-
Our clientele includes a mix of tumor ablation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into France tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France tumor ablation market size, by technology, 2018-2030 (US$M)
France Tumor Ablation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
